CN101816776B - Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof - Google Patents
Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof Download PDFInfo
- Publication number
- CN101816776B CN101816776B CN2010101902048A CN201010190204A CN101816776B CN 101816776 B CN101816776 B CN 101816776B CN 2010101902048 A CN2010101902048 A CN 2010101902048A CN 201010190204 A CN201010190204 A CN 201010190204A CN 101816776 B CN101816776 B CN 101816776B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- menstrual cycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000027758 ovulation cycle Effects 0.000 title claims abstract description 60
- 230000003111 delayed effect Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title abstract description 47
- 230000002175 menstrual effect Effects 0.000 title abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 62
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims description 18
- 241000717739 Boswellia sacra Species 0.000 claims description 12
- 241000756943 Codonopsis Species 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 241000283956 Manis Species 0.000 claims description 12
- 241001057584 Myrrha Species 0.000 claims description 12
- 239000010271 massa medicata fermentata Substances 0.000 claims description 12
- 210000002826 placenta Anatomy 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- 241000407170 Curcuma Species 0.000 claims description 11
- 235000014375 Curcuma Nutrition 0.000 claims description 11
- 235000005903 Dioscorea Nutrition 0.000 claims description 11
- 241000234273 Dioscorea Species 0.000 claims description 11
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 11
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 11
- 235000004879 dioscorea Nutrition 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 239000011550 stock solution Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 14
- 210000001015 abdomen Anatomy 0.000 abstract description 11
- 230000005906 menstruation Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 210000000481 breast Anatomy 0.000 abstract description 5
- 210000004914 menses Anatomy 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 230000003821 menstrual periods Effects 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 8
- 230000035761 normovolemia Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010016256 fatigue Diseases 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 108010052008 colla corii asini Proteins 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a novel Chinese medicinal composition for treating delayed menstrual cycle and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: root of red-rooted salvia, szechuan lovage rhizome, safflower, peach seed, roasted pangolin scales, motherwort herb, medlar, tuber fleeceflower root, white paeony root, piloseasiabell root, raw astragalus, cinnamomvine, Chinese angelica, roasted frankincense, roasted myrrh, cassia bark, cassia twig, dried ginger, medcinal evodia fruit, tangerine peel, green tangerine peel, immature bitter orange, cyperusrotundus, szechwan chinaberry fruit, rhizoma corydalis, radix curcumae, suberect spatholobus stem, cowherb seed, radix rehmanniae preparata, donkey-hide glue and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: delayed menstrual cycle, delayed menstruation, delayed menstrual cycle, scant menstrual flow, lumpy menses with dark color, lesser abdomen, distention and pain of the breast, depression, lusterless complexion, fatigue and lack of strength and other symptoms, and has the advantages of extract clinical treatment effect, remarkable treatment effect, quick response, basically no toxic or side effect and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of delayed menstrual cycle.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment delayed menstrual cycle of crude drug with the Chinese herbal medicine.
Background technology
[0002] menstrual cycle was delayed more than 7 days, even delegation on the four or five ten, and menstrual period, normal person occurred two more than the cycle continuously, was called " delayed menstrual cycle ", also was called " delayed menstrual cycle ", " opsomenorrhea ".As only delaying three or five days at every turn, or accidental delaying 1 time, still rise as scheduled next time, all do not make the delayed menstrual cycle opinion.In addition, or behind the adolescence menarche in the several months, or before climacteric menstruation stops, delay during menstrual period, as do not have other patients, also be not considered as " delayed menstrual cycle ".Primary disease is equivalent to the hypomenorrhea of western medicine.The traditional Chinese medical science is divided into blood-cold type, asthenic cold type, blood-deficiency type, Qi-stagnation type, phlegm retention etc. with it.Delayed menstrual cycle is common gynecological disease, frequently-occurring disease, normal occurs simultaneously less with menstrual blood volume, as treats in time properly, and generally prognosis is better.But if control untimely or control and do not work as, then deficiency and excess no matter all can develop into amenorrhea.In recent years the clinical onset rate has the trend of continuous rising.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment delayed menstrual cycle, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of dispelling cold by warming the meridian, tonifying blood and regulating menstruation, promoting flow of QI and blood,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment delayed menstrual cycle that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment delayed menstrual cycle of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of delayed menstrual cycle of the present invention, the component of main following weight portion is formed:
1～120 part of Radix Salviae Miltiorrhizae, 1～100 part of Rhizoma Chuanxiong, 1～50 part on Flos Carthami, 1～50 part in Semen Persicae, 1～50 part of Squama Manis (processed), 1～300 part of Herba Leonuri, 1～150 part of Fructus Lycii, 1～50 part of Placenta Hominis, 1～200 part of Radix Polygoni Multiflori, 1～300 part of the Radix Paeoniae Alba, 1～150 part of Radix Codonopsis, 1～300 part of Radix Astragali, 1～300 part of Rhizoma Dioscoreae, 1～200 part of Radix Angelicae Sinensis, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～50 part of Cortex Cinnamomi, 1～100 part of Ramulus Cinnamomi, 1～100 part of Rhizoma Zingiberis, 1～50 part of Fructus Evodiae, 1～300 part of Pericarpium Citri Reticulatae, 1～100 part on Pericarpium Citri Reticulatae Viride, 1～150 part of Fructus Aurantii Immaturus, 1～300 part of Rhizoma Cyperi, 1～150 part of Fructus Toosendan, 1～150 part of Massa Medicata Fermentata, 1～150 part in Fructus Hordei Germinatus, 1～150 part of Rhizoma Corydalis, 1～120 part of Radix Curcumae.
Be preferably:
30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～150 part in Rhizoma Curcumae Longae, 1～120 part of Herba Lycopi, 1～100 part of Radix Achyranthis Bidentatae, 1～100 part of Caulis Spatholobi, 1～150 part of Semen Vaccariae, 1～100 part of Benzoinum, 1～120 part of Rhizoma Acori Graminei, 1～120 part of Radix Rehmanniae Preparata, 1～100 part in Colla Corii Asini, 1～120 part of Fructus Ligustri Lucidi, 1～100 part of Radix Ophiopogonis, 1～100 part of Radix Asparagi, 1～100 part of Herba Dendrobii, 1～100 part of Rhizoma Polygonati Odorati, 1～50 part of Fructus Psoraleae, 1～50 part of Semen Cuscutae, 1～50 part of Semen Astragali Complanati.
Be preferably:
30 parts in Rhizoma Curcumae Longae, 20 parts of Herba Lycopi, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Caulis Spatholobis, 30 parts of Semen Vaccariae, 20 parts of Benzoinumes, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Rehmanniae Preparata, 20 parts in Colla Corii Asini, 20 parts of Fructus Ligustri Lucidi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Fructus Psoraleaes, 15 parts of Semen Cuscutae, 15 parts of Semen Astragali Complanatis.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the delayed menstrual cycle patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion: 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating delayed menstrual cycle of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 58 routine patients altogether, wherein male 0 example, women 58 examples; The oldest person 54 years old, the age reckling has only 15 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 3 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and be happy, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, fourth so-and-so, woman, 24 years old.
Main suit: delayed menstrual cycle 3 years.3 years causes of patient identify oneself fat, take medicine again, go on a diet again, and back health is gradually thin, and diet is few, poor appetite, then after the menstrual cycle mistake, rose once in general 3 to 5 months, through going 3-4 days, light through color, matter is rare, no piece is accompanied the empty dull pain of weighing down of lower abdomen menstrual period, dizziness and blurred vision usually, fatigue and weak, cardiopalmus.Yellow complexion is simple and unadorned, light red tongue, thready pulse.
Took Chinese medicine composition of the present invention 10, menstrual onset, light through color, matter is rare, and through row 4 days, the empty dull pain of weighing down of lower abdomen was alleviated slightly, still feels fatigue and weak.Continue and obeyed Chinese medicine composition of the present invention 1 month, dizziness and blurred vision, fatigue and weak, cardiopalmus remission.Next month menstrual onset, menstrual cycle 30 days changes red through color, through row 5 days, the sense of the empty bob of no lower abdomen dull pain.The clothes Chinese medicine composition of the present invention 1 month that continues, next month menstrual onset, menstrual cycle 29 days, color normovolemia.Followed up a case by regular visits to 3 months, menstrual cycle is normal.
2, Lee, woman, 27 years old.
Main suit: delayed menstrual cycle nearly half a year.Patient's last Nov menstrual onset, 12 moonsets come.This year, menstruation on January 24 was risen, and February is not until all come March 24 today.Do not have obvious dysmenorrhea at ordinary times menstrual period, through fore udder distending pain is arranged slightly, health is aching and limp, and emotional instability is hard and dry, lassitude.Red tip of the tongue, thready pulse.
Took Chinese medicine composition of the present invention 15, menstrual onset, through row 6 days, amount was few, and color is light red, and fatigue and weakness is alleviated to some extent.Continue and obeyed Chinese medicine composition of the present invention 15, stool is normal, and sleep improves, and receives to increase.The clothes Chinese medicine composition of the present invention 5 days that continues, next month menstrual onset, menstrual cycle 30 days, color normovolemia.The clothes Chinese medicine composition of the present invention that continues was consolidated 1 month, and the patient has rosy cheeks, and spirit is good.Followed up a case by regular visits to 2 months, menstrual cycle is normal.
3, Cao, woman, 23 years old.
The main suit: delayed menstrual cycle for many years.Menstrual history: 17 years, the moon was often delayed 7～20, and clot is arranged in the amount through menophania.Last menstrual period, surplus menstruation delays 10 day, through row 3 days, the few color of amount was dark, has held clot under the arm, companion's soreness of waist pain, lower abdomen weighs down and expands.Patient's facial colour spot is obvious, and color is dark, white and thin fur, thready and stringy pulse.
Took Chinese medicine composition of the present invention 5, menstrual onset, through row 5 days, amount was few, and color is dark red, and lower abdomen has slightly to weigh down and expands.Continue and obeyed Chinese medicine composition of the present invention 15, patient's complexion takes a turn for the better.The clothes Chinese medicine composition of the present invention 7 days that continues, next month menstrual onset, menstrual cycle 30 days, color normovolemia, no clot.The clothes Chinese medicine composition of the present invention that continues was consolidated 25, and the patient has rosy cheeks, and sleeps.Followed up a case by regular visits to 3 months, menstrual cycle is normal.
4, the village so-and-so, woman, 32 years old.
The main suit: delayed menstrual cycle is many half a year.Nearly menstruation half a year of patient is undesired, delays menstrual period about 10 days, and amount is few, and color is dim clot, with cold and pain in the lower abdomen, hot alleviating, aversion to cold and cold limbs.Pallor is simple and unadorned, and tongue is white, deep and tense pulse.
Took Chinese medicine composition of the present invention 10, patient's body sympotoms caused by cold factors shape is alleviated, and sleep takes a turn for the better.The clothes Chinese medicine composition of the present invention 1 month that continues, patient's complexion takes a turn for the better, next month menstrual onset, lower abdomen does not have cold type of pain, clot disappears.The clothes Chinese medicine composition of the present invention 20 days that continues, next month menstrual onset, menstrual cycle 30 days, the color normovolemia, no clot, menstrual cycle is normal.
5, money so-and-so, woman, 25 years old.
The main suit: delayed menstrual cycle for many years.Patient's menophania evening, 17 years, the delayed menstrual cycle amount was few through menophania, and color is light, dizziness and tinnitus, waist soreness.Surplus menstruation delayed ten in the past day, but menstruation last time so far February surplus, not extremely not always.Light red tongue, tongue is few, deep and weak pulse.
Took Chinese medicine composition of the present invention 5, menstrual onset, amount is few, and color is light red, waist soreness.Continue and obeyed Chinese medicine composition of the present invention 15, sleep improves, and receives to increase.The clothes Chinese medicine composition of the present invention 5 days that continues, next month menstrual onset, menstrual cycle 31 days, through row 5 days, color normovolemia, waist soreness alleviates.The clothes Chinese medicine composition of the present invention that continues was consolidated 15, and patient's complexion is good, and is in high spirits.Followed up a case by regular visits to 2 months, menstrual cycle is normal.
6, leaf, woman, 29 years old.
Main suit: delayed menstrual cycle 1 year.Patient's delayed menstrual cycle 1 year, 7-8 day is delayed in menstruation, amount is few, the red matter of color is thick, menstrual period distending pain of the breast, with headache and dizziness, lack of appetite, weak, the time desire sigh dryness of the mouth and throat.Light red tongue, stringy pulse and void.
Took Chinese medicine composition of the present invention 7, patient's body constitution is clearly better.Continue and obeyed Chinese medicine composition of the present invention 15, patient's complexion takes a turn for the better, and next month, menstrual onset before increased through amount, and the red matter of color is thick, and menstrual period, breast did not have distending pain.Clothes Chinese medicine composition of the present invention 1 first quarter moon that continues, next month menstrual onset, menstrual cycle 30 days, the color normovolemia, breast does not have distending pain, menstrual period are normal.
7, history so-and-so, woman, 27 years old.
Main suit: delayed menstrual cycle 3 months.Patient menstrual cycle 31-32 days in the past through going 6-7 days, compares rule.Sky surplus nearest 3 menstrual phases delay 10, few for a long time when amount, menses are mingled with mucus.Color is light, and matter is thick, and is with many matter thick at ordinary times, usually cough ant phlegm.Patient's body constitution obesity, thick and greasy fur, stringy and rolling pulse.
Took Chinese medicine composition of the present invention 7, the more preceding minimizing of patient leucorrhea.The clothes Chinese medicine composition of the present invention 20 days that continues, patient's menstrual onset next month, menstrual cycle 32 days, through row 7 days, color was red, and menses are mingled with mucus to be reduced.The clothes Chinese medicine composition of the present invention 1 month that continues, next month menstrual onset, menstrual cycle 31 days, through row 7 days, color normovolemia, no mucus is mingled with, leukorrhagia is normal at ordinary times, menstrual period are normal.
8, still certain, woman, 40 years old.
Main suit: delayed menstrual cycle 5 months.Patient's menstrual cycle in the past is normal, through row six or seven days, and rule relatively.Nearly 5 menstrual phases are all delayed 8-10 days, and through row four or five days, the few color of amount was light red, and matter is rare clearly, no clot; Cold-type pain in the lower abdomen during menstruation, desire for warm and being pressed, the soreness of waist is unable, coldness of the body with chills.The rolling of patient's complexion is white, and it is thin to defecate, light red tongue, and tongue is white, and weak pulse is unable.
Took Chinese medicine composition of the present invention 7, patient's body constitution takes a turn for the better to some extent, and stool is normal.The clothes Chinese medicine composition of the present invention 7 days that continues, patient's menstrual onset next month, through row 7 days, it is red that color changes, and cold and pain in the lower abdomen is more preceding obviously to be alleviated.The clothes Chinese medicine composition of the present invention 1 month that continues, next month menstrual onset, menstrual cycle 30 days through row 7 days, color normovolemia, is not felt cold and pain in the lower abdomen, the soreness of waist is unable.Followed up a case by regular visits to 3 months, menstrual cycle is normal.
Five, therapeutic outcome:
In the 58 routine cases of being accepted for medical treatment,, wherein cure 13 examples through treatment in 3 months, produce effects 23 examples, effective 18 examples, invalid 4 examples, total effective rate reaches 93 %.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment delayed menstrual cycle patient.
Claims (10)
1. Chinese medicinal capsule agent for the treatment of delayed menstrual cycle, it is characterized in that: take by weighing each raw material: 30 parts of Radix Salviae Miltiorrhizaes by following weight portion, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes grind into after each component of above-mentioned weight mixed and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
2. Chinese medicine granules for the treatment of delayed menstrual cycle, it is characterized in that: take by weighing each raw material: 30 parts of Radix Salviae Miltiorrhizaes by following weight portion, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes, each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
3. Chinese medicinal tablet for the treatment of delayed menstrual cycle, it is characterized in that: take by weighing each raw material: 30 parts of Radix Salviae Miltiorrhizaes by following weight portion, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes, each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
4. medicine pill for the treatment of delayed menstrual cycle, it is characterized in that: take by weighing each raw material: 30 parts of Radix Salviae Miltiorrhizaes by following weight portion, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes, each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
5. Chinese medicine oral liquid for the treatment of delayed menstrual cycle, it is characterized in that: take by weighing each raw material: 30 parts of Radix Salviae Miltiorrhizaes by following weight portion, 30 parts of Rhizoma Chuanxiongs, 15 parts on Flos Carthami, 15 parts in Semen Persicae, 15 parts of Squama Manis (processed), 50 parts of Herba Leonuris, 50 parts of Fructus Lycii, 15 parts of Placenta Hominiss, 50 parts of Radix Polygoni Multiflori, 50 parts of the Radix Paeoniae Albas, 30 parts of Radix Codonopsis, 60 parts of Radix Astragali, 50 parts of Rhizoma Dioscoreaes, 50 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 15 parts of Cortex Cinnamomis, 20 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Zingiberiss, 15 parts of Fructus Evodiaes, 50 parts of Pericarpium Citri Reticulataes, 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 30 parts of Massa Medicata Fermentata, 30 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Corydalis, 20 parts of Radix Curcumaes, each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
6. the application of the described Chinese medicinal capsule agent of claim 1 in preparation treatment delayed menstrual cycle medicine.
7. the application of the described Chinese medicine granules of claim 2 in preparation treatment delayed menstrual cycle medicine.
8. the application of the described Chinese medicinal tablet of claim 3 in preparation treatment delayed menstrual cycle medicine.
9. the application of the described medicine pill of claim 4 in preparation treatment delayed menstrual cycle medicine.
10. the application of the described Chinese medicine oral liquid of claim 5 in preparation treatment delayed menstrual cycle medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101902048A CN101816776B (en) | 2010-06-03 | 2010-06-03 | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101902048A CN101816776B (en) | 2010-06-03 | 2010-06-03 | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101816776A CN101816776A (en) | 2010-09-01 |
| CN101816776B true CN101816776B (en) | 2011-12-14 |
Family
ID=42652153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101902048A Expired - Fee Related CN101816776B (en) | 2010-06-03 | 2010-06-03 | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816776B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205103B (en) * | 2011-05-13 | 2012-09-12 | 吴玉平 | Pure Chinese medicinal plaster for treating dysmenorrhea |
| CN104721468A (en) * | 2015-02-27 | 2015-06-24 | 金科 | Traditional Chinese medicine composition for treating irregular menstruation |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552857A (en) * | 2012-02-13 | 2012-07-11 | 李承平 | Capsule for removing blood stasis for promoting tissue regeneration after childbirth |
| CN102697974B (en) * | 2012-06-01 | 2015-01-21 | 何圣 | Externally applied female health-care Chinese medicine |
| CN103251901B (en) * | 2013-04-22 | 2015-05-27 | 山东大学齐鲁医院 | Oral traditional Chinese medicine preparation for treating dysmenorrhea |
| CN103356981B (en) * | 2013-06-07 | 2015-06-17 | 王爱华 | Traditional Chinese medicine for treating female irregular menstruation |
| CN103536887B (en) * | 2013-10-30 | 2015-05-13 | 贾贵玲 | Traditional Chinese medicament for treating hypomenorrhea with symptoms of blood stasis and channel blockage |
| CN104587131A (en) * | 2015-02-15 | 2015-05-06 | 孙红梅 | Traditional Chinese medicinal composition for treating delayed menorrhea |
| CN104784573B (en) * | 2015-04-27 | 2018-03-20 | 中国人民解放军总医院 | A kind of 1 levels in female patients with acne for the treatment of occurs together the traditional Chinese herbal decoction of irregular menstruation |
| CN104784477A (en) * | 2015-05-05 | 2015-07-22 | 淄博齐鼎立专利信息咨询有限公司 | Traditional Chinese medicine composition for treating delayed menstrual cycle |
| CN106039265A (en) * | 2016-07-14 | 2016-10-26 | 郑州五行舒体商贸有限公司 | Regular nourishing herbal membrane |
| CN106215104A (en) * | 2016-08-24 | 2016-12-14 | 沈友良 | A kind of Chinese medicine composition treating menoxenia, amenorrhea |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998722B (en) * | 2006-12-28 | 2010-04-21 | 王玉秀 | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia |
-
2010
- 2010-06-03 CN CN2010101902048A patent/CN101816776B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205103B (en) * | 2011-05-13 | 2012-09-12 | 吴玉平 | Pure Chinese medicinal plaster for treating dysmenorrhea |
| CN104721468A (en) * | 2015-02-27 | 2015-06-24 | 金科 | Traditional Chinese medicine composition for treating irregular menstruation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101816776A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816776B (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
| CN101708327B (en) | Chinese medicinal composition for treating diseases of weakness of spleen and stomach and indigestion and preparation method thereof | |
| CN101785844B (en) | Traditional Chinese medicine combination and preparation method thereof for dysentery treatment | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101816770B (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN101757403B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN101810816B (en) | Chinese medicinal composition for treating abnormal vaginal discharge and preparation method thereof | |
| CN101757528A (en) | Traditional Chinese medicine composition for treating symptoms of deficiency of kidney yin and soreness and weakness of waist and knees and preparation method thereof | |
| CN101785845B (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN101856474B (en) | Chinese medicinal composition for treating hypomenorrhea and preparation method thereof | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN101816758B (en) | Traditional Chinese medicine composition for treating preceded menstrual cycle and preparation method thereof | |
| CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
| CN101961464A (en) | Chinese medicinal composition for treating jaundice and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101972457A (en) | Chinese medicinal composition for treating edema during menstruation and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101966319A (en) | Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof | |
| CN101837113A (en) | Chinese medicinal composition for curing fever during menstruation and preparation method thereof | |
| CN101829308A (en) | Traditional Chinese medicine combination for treating amenorrhea and preparation method thereof | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof | |
| CN101843888B (en) | Novel Chinese medicinal composition for treating menorrhagia and a preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111214 Termination date: 20130603 |